| [공지] |
2026년 학회 및 전시정보  |
관리자 |
2026.01.01 |
139 |
| 55 |
[Citation] Blockade of Activin Receptor IIB Protects Arthritis Pathogenesis |
관리자 |
2026.03.02 |
37 |
| 54 |
[Citation] Exercise-induced CLCF1 attenuates age-related muscle and bone decline in mice |
관리자 |
2026.02.20 |
79 |
| 53 |
[논문] Antibodies to watch in 2026 |
관리자 |
2026.02.03 |
92 |
| 52 |
[Technical Support] Affinity Service |
관리자 |
2026.01.23 |
128 |
| 51 |
[논문] Immunogenicity risk mitigation of therapeutic proteins with translational immunogenicity, |
관리자 |
2025.12.15 |
298 |
| 50 |
[Citation] Del-1, an Endogenous Inhibitor of TGF-β Activation, Attenuates Fibrosis |
관리자 |
2025.11.26 |
302 |
| 49 |
[논문] Developability considerations for bispecific and multispecific antibodies |
관리자 |
2025.11.18 |
210 |
| 48 |
[Citation] Endogenous DEL-1 restrains melanoma lung metastasis by limiting |
관리자 |
2025.11.11 |
259 |
| 47 |
[논문] Bispecific antibodies: advancing precision oncology |
관리자 |
2025.11.03 |
284 |
| 46 |
[Citation] Colony-stimulating factor 3 |
관리자 |
2025.10.17 |
338 |
| 45 |
[논문] Quantifying antibody binding techniques and therapeutic implications |
관리자 |
2025.08.18 |
588 |
| 44 |
[논문] T cell- specific non- viral DNA delivery and in vivo CAR- T generation using targeted lipid nanoparticles |
관리자 |
2025.08.18 |
530 |
| 43 |
Discovery Antibody Screening Services |
관리자 |
2025.07.23 |
446 |
| 42 |
[논문] Translational minimal physiologically based pharmacokinetic model for transferrin receptor-mediated brain delivery |
관리자 |
2025.06.30 |
444 |
| 41 |
[논문] Leveraging neonatal Fc receptor (FcRn) to enhanceantibodytransportacrosstheblood brain barrier |
관리자 |
2025.06.30 |
413 |
| 40 |
Ymax®-NANO : A Single Domain Antibody Library |
관리자 |
2025.06.30 |
709 |
| 39 |
[논문] TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer |
관리자 |
2025.06.01 |
408 |
| 38 |
[논문] Antibodies to watch in 2025 |
관리자 |
2025.02.05 |
1,317 |
| 37 |
[서비스 브로셔] Human Nanobody Screening |
관리자 |
2025.01.02 |
806 |
| 36 |
[논문] Facilitating high throughput bispecific antibody production and potential applications within ... |
관리자 |
2024.11.29 |
666 |
